Montefarm, Montenegro’s state-owned pharmaceutical wholesaler and distributor, has reported robust financial performance and a reliable supply chain throughout 2025, crucial for supporting the public healthcare system amid rising costs and global supply challenges. According to the company’s Director, Aleksandar Bogavac, effective financial management, rigorous cash-flow planning, and close collaboration with the Health Insurance Fund have been vital in maintaining liquidity and ensuring consistent access to medicines and medical supplies.
Bogavac highlighted that regular funding from the Health Insurance Fund and stringent expenditure controls have allowed Montefarm to fulfill its obligations to suppliers punctually, ensuring ongoing deliveries to a network of 55 state pharmacies and all public healthcare institutions nationwide. He noted that the company prioritizes operational reliability over commercial profitability, reflecting its essential role in Montenegro’s public health framework.
In reviewing the previous year’s activities, Bogavac characterized 2025 as a time of operational stability and gradual enhancement despite external challenges. Key accomplishments included targeted cost rationalization, improved internal processes, and enhanced logistics efficiency. Throughout the year, pharmacies within the Montefarm network consistently received supplies without significant shortages. In addition to retail distribution, Montefarm also supports hospitals, emergency services, and national vaccination programs, underscoring its strategic importance in healthcare delivery.
Despite ongoing disruptions in global pharmaceutical supply chains due to production delays and raw material shortages, Montefarm has successfully maintained supply continuity. Bogavac explained that proactive procurement strategies, ongoing supplier communication, and sourcing of equivalent medications approved by Montenegro’s official pharmaceutical list have been effective in mitigating potential disruptions. In cases of delays, alternative procurement methods and internal stock redistribution are implemented to minimize impacts on patients and healthcare providers.
The rising costs of medicines, energy, and logistics have intensified operational pressures; however, Montefarm has responded by optimizing distribution routes, enhancing warehouse efficiency, and tightening cost controls. Bogavac emphasized that Montefarm does not set medicine prices as they are regulated through national procurement frameworks. The company’s role is to ensure transparent procurement processes and stable supply while responsibly managing public funds.
Montefarm’s liquidity remains stable with timely supplier payments corresponding to funding transfers from the Health Insurance Fund. Bogavac pointed out that predictable funding is essential for ensuring continuous deliveries and maintaining trust with both domestic and international suppliers. Coordination with the Ministry of Health and the Health Insurance Fund facilitates better planning, reduces risks of shortages, and aligns healthcare needs with available resources.
In addressing ongoing global challenges such as shortages of older or less commercially viable medications, Bogavac noted that improved risk management practices have reduced exposure. These measures include maintaining higher safety stocks for critical drugs and diversifying supplier sources. When a contracted supplier fails to deliver, Montefarm can obtain necessary medications from alternative authorized distributors to stabilize the market and safeguard patient access. However, sourcing specialized medications for rare or complex conditions continues to be challenging due to regulatory requirements and import limitations.
Montefarm is also pursuing modernization initiatives through investments in digital systems aimed at enhancing inventory management, demand forecasting, and distribution oversight. The implementation of advanced digital tools is already improving operational visibility and expediting decision-making processes. Looking forward, the company plans to expand its pharmacy network with new locations slated for Sutomore and central Podgorica to enhance accessibility and alleviate pressure on existing facilities.
Strategic infrastructure development is part of future plans as well, including the construction of a modern distribution center adhering to European standards. As Montefarm celebrates 35 years of operation, management considers these investments crucial for bolstering long-term resilience and ensuring that Montenegro’s public healthcare system remains consistently supplied amid an increasingly complex pharmaceutical landscape.
